An observational study in Anal Fistula, sponsored by Cook Group Incorporated. Completed at 8 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2015-02-11.
Sponsored by Cook Group Incorporated · Observational
The LIFT+Biodesign® study is a post-market observational study to evaluate the rate of fistula closure in patients with persistent trans-sphincteric anal fistula who receive the Biodesign® Tissue graft as part of their LIFT procedure.
189 studies on the registry are indexed under Rectal Fistula; 42 are open to participants now.
This study's enrollment of 28 is below the median of 94 across 50 observational studies indexed under Rectal Fistula.
Browse Rectal Fistula studies →Cook Group Incorporated is the lead sponsor of 73 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Regional and Community Hospitals
Exclusion Criteria:
Device: reinforce soft tissue
reinforce soft tissue
Closure of the anal fistula
Time frame: 6 months
Closure of the anal fistula
Time frame: 12 months
This study is completed, as verified in Feb 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Cook Group Incorporated